Ledipasvir/sofosbuvir ± ribavirin for 12 or 24 weeks is safe and effective in children 6-11 years old with chronic hepatitis C infection

Authors
Category Primary study
JournalJournal of Hepatology
Year 2017
This article has no abstract
Epistemonikos ID: 8a8c32f72adb327cb4eddc12d42ecc8c7dc43999
First added on: Feb 09, 2025